Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.085 USD | +1.40% | -5.31% | +23.70% |
08/05 | Earnings Flash (KPTI) KARYOPHARM THERAPEUTICS Reports Q1 Revenue $33.1M, vs. Street Est of $34.5M | MT |
08/05 | Transcript : Karyopharm Therapeutics Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.70% | 125M | |
+3.16% | 108B | |
+10.93% | 104B | |
+1.28% | 22.33B | |
-12.86% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.97% | 17.64B | |
+4.11% | 14.05B | |
+35.20% | 12.51B |
- Stock Market
- Equities
- KPTI Stock
- News Karyopharm Therapeutics Inc.
- RBC Cuts Price Target on Karyopharm Therapeutics to $5 From $6, Maintains Outperform Rating